BioCardia, Inc. (BCDA)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.79
- As of
Kresmion compiles this page from BCDA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BioCardia, Inc. (BCDA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-12.
See the full BCDA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BCDA on one page. Preview it with sample data, then open it live with a free account.
Preview the BCDA dossierActive events for BCDA
- mediumEarnings above estimates
Q3-2026: Beat consensus by 9.5%, EPS $-0.12 vs $-0.1326 estimate
- mediumEarnings above estimates
Q2-2026: Beat consensus by 29.2%, EPS $-0.13 vs $-0.1836 estimate
- high13F: large reduction
CITADEL ADVISORS LLC cut 76% of BCDA (2026Q2)
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in BCDA
- mediumEarnings above estimates
Beat consensus by 21.6% - EPS $-0.4 vs $-0.51 estimate
FREE, NO ACCOUNT
Every event on BCDA, as it fires
You are seeing 5 of 7 events recorded on BCDA since 2026-06-15.
The five above landed across 4 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, BCDA
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
BCDA's 10-Q filed Nov 12, 2026 states:
These factors raise substantial doubt about our ability to continue as a going concern beyond one year from the date these financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on BCDA
BCDA against its peers
BCDA's return on equity of -919.3% ranks in the 8th percentile of 19 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.
| Metric | BCDA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 0.0 USD | 1.0M USD | 11 | 13 |
| Gross margin | n/a | 64.8% | n/a | 5 |
| Operating margin | n/a | -1315.4% | n/a | 11 |
| Net margin | n/a | -1256.8% | n/a | 11 |
| Return on equity | -919.3% | -151.2% | 8 | 19 |
| 1 year | -40.1% | -61.2% | 66 | 18 |
Peers (23): PASG, TVRD, TCRX, AEON, DARE, ADIL, SYBX, CLGN, DYAI, INTI, GUTS, CLRB, HEPA, BIVI, ASBP, CKDXF, PBM, ANEB, PTN, MRKR, BOLT, LSTA, HIND. Left out: QNTM (no annual filing), HOOK.D (period gap). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BCDA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BCDA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BCDA in the last 180 days.
Upstream: SEC EDGAR filings for BCDA
Kresmion, "BioCardia, Inc. (BCDA) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/BCDA. Upstream data: SEC EDGAR filings for BCDA.
Link to this data (HTML):
<a href="https://kresmion.com/research/BCDA">BioCardia, Inc. (BCDA) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BCDA on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BCDA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.